Penumbra Inc (NYSE:PEN) EVP Johanna Roberts sold 1,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 7th. The stock was sold at an average price of $150.00, for a total transaction of $150,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
PEN stock traded down $5.38 on Friday, hitting $150.20. 441,838 shares of the company’s stock traded hands, compared to its average volume of 431,373. Penumbra Inc has a 1-year low of $82.55 and a 1-year high of $167.35. The firm has a market cap of $5.40 billion, a PE ratio of -15,020.00, a P/E/G ratio of 16.47 and a beta of 0.41.
Penumbra (NYSE:PEN) last released its earnings results on Monday, November 5th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.03 by $0.14. Penumbra had a net margin of 2.15% and a return on equity of 4.21%. The business had revenue of $111.80 million during the quarter, compared to analyst estimates of $103.59 million. During the same period in the prior year, the business earned $0.01 earnings per share. The business’s quarterly revenue was up 33.3% on a year-over-year basis. Equities analysts forecast that Penumbra Inc will post 0.47 earnings per share for the current year.
A number of analysts have recently weighed in on the stock. TheStreet raised shares of Penumbra from a “d+” rating to a “c” rating in a research note on Monday, September 17th. ValuEngine raised shares of Penumbra from a “hold” rating to a “buy” rating in a research note on Wednesday, September 12th. Zacks Investment Research raised shares of Penumbra from a “hold” rating to a “buy” rating and set a $157.00 price target for the company in a research note on Wednesday. BMO Capital Markets upped their price target on shares of Penumbra from $150.00 to $152.00 and gave the stock a “market perform” rating in a research note on Tuesday. Finally, Bank of America reissued a “buy” rating and set a $36.00 target price on shares of Penumbra in a research note on Monday, October 29th. Two research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $145.57.
COPYRIGHT VIOLATION NOTICE: “Penumbra Inc (PEN) EVP Johanna Roberts Sells 1,000 Shares of Stock” was originally posted by WKRB News and is owned by of WKRB News. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark and copyright law. The legal version of this piece of content can be accessed at https://www.wkrb13.com/2018/11/10/penumbra-inc-pen-evp-johanna-roberts-sells-1000-shares-of-stock.html.
Penumbra Company Profile
Penumbra, Inc designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands; aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the ACE and the 3D Revascularization Device brands.
Further Reading: What are the risks of holding treasury bonds?
Receive News & Ratings for Penumbra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Penumbra and related companies with MarketBeat.com's FREE daily email newsletter.